Literature DB >> 601516

Unsaturated and cobalamin saturated transcobalamin I and II in normal human plasma.

E Nexø, J Andersen.   

Abstract

Insolubilized antibody against human transcobalamin I has been used as a specific and precise tool for the separation of transcobalamin I (and III) from transcobalamin II. Range and mean (in parentheses) for the unsaturated binding capacity for twenty samples are 40-190 (90) pmol/l and 220-1170 (560) pmol/l for transcobalamin I (and III) and transcobalamin II, respectively. The similar figures for the cobalamin saturated transcobalamins are 200-549 (320) pmol/l and 75-475 (160 pmol/l. On analyses of the cobalamins attached to each of the transcobalamins, it is shown that methylcobalamin accounts for most of the cobalamins attached to transcobalamin I whereas transcobalamin II carries most of the 5'-deoxyadenosylcobalamin.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 601516     DOI: 10.3109/00365517709101856

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  5 in total

1.  Cobalamins and cobalamin-dependent enzymes in Candida utilis.

Authors:  J M Poston; B A Hemmings
Journal:  J Bacteriol       Date:  1979-12       Impact factor: 3.490

Review 2.  Vitamin B-12 and Perinatal Health.

Authors:  Julia L Finkelstein; Alexander J Layden; Patrick J Stover
Journal:  Adv Nutr       Date:  2015-09-15       Impact factor: 8.701

3.  A Salmonella typhimurium cobalamin-deficient mutant blocked in 1-amino-2-propanol synthesis.

Authors:  C Grabau; J R Roth
Journal:  J Bacteriol       Date:  1992-04       Impact factor: 3.490

Review 4.  Diagnostic and Therapeutic Perspectives Associated to Cobalamin-Dependent Metabolism and Transcobalamins' Synthesis in Solid Cancers.

Authors:  Valentin Lacombe; Guy Lenaers; Geoffrey Urbanski
Journal:  Nutrients       Date:  2022-05-14       Impact factor: 6.706

Review 5.  Holotranscobalamin, a marker of vitamin B-12 status: analytical aspects and clinical utility.

Authors:  Ebba Nexo; Elke Hoffmann-Lücke
Journal:  Am J Clin Nutr       Date:  2011-05-18       Impact factor: 7.045

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.